These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38629631)

  • 41. Medicaid patients increasingly concentrated among physicians.
    Cunningham P; May J
    Track Rep; 2006 Aug; (16):1-5. PubMed ID: 16918046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medicaid coverage of maternity care for aliens in California.
    Norton SA; Kenney GM; Ellwood MR
    Fam Plann Perspect; 1996; 28(3):108-12. PubMed ID: 8827146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Competition in California's Medi-Cal Managed Care Market Assessed by Herfindahl-Hirschman Index.
    Tawil M; DiGiorgio AM
    Inquiry; 2022; 59():469580221127063. PubMed ID: 36168304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cost of topical immunomodulator therapy in Medicare patients varies by prescriber specialty.
    Zhang M; Silverberg JI; Kaffenberger BH
    J Am Acad Dermatol; 2017 May; 76(5):925-931. PubMed ID: 28162853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insurers pursuing Medi-Cal patients.
    Lehrman S
    J Okla State Med Assoc; 1995 Oct; 88(10):445-7. PubMed ID: 7472713
    [No Abstract]   [Full Text] [Related]  

  • 46. Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances.
    Chen A; Blumenthal DM; Jena AB
    JAMA Netw Open; 2018 Dec; 1(8):e185805. PubMed ID: 30646294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptance of new patients with public and private insurance by office-based physicians: United States, 2013.
    Hing E; Decker S; Jamoom E
    NCHS Data Brief; 2015 Mar; (195):1-8. PubMed ID: 25932895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance.
    Mann A; Esse T; Abughosh SM; Serna O
    J Manag Care Spec Pharm; 2016 Jan; 22(1):49-55. PubMed ID: 27015051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-income Californians' experiences with health insurance and managed care.
    Backus LI; Bindman AB
    J Health Care Poor Underserved; 2001 Nov; 12(4):446-60. PubMed ID: 11688195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The "Birth-Centered Outcomes Research Engagement (B-CORE) in Medi-Cal" Project: Community-Generated Recommendations to Decrease Maternal Mortality and Severe Maternal Morbidity.
    Batra P; Alvarado G; Bird CE
    Womens Health Issues; 2023; 33(5):474-480. PubMed ID: 37169636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
    Neprash HT; Golberstein E; Ganguli I; Chernew ME
    JAMA; 2023 Feb; 329(8):662-669. PubMed ID: 36853249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specialists' and primary care physicians' participation in medicaid managed care.
    Backus L; Osmond D; Grumbach K; Vranizan K; Phuong L; Bindman AB
    J Gen Intern Med; 2001 Dec; 16(12):815-21. PubMed ID: 11903760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program.
    Jacobs J; Keyserling JA; Britton M; Morgan GJ; Wilkenfeld J; Hutchings HC
    J Clin Epidemiol; 1988; 41(3):215-23. PubMed ID: 3123614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The return of two-class medicine--ill effects of Medi-Cal reform.
    Waitzkin H
    West J Med; 1985 May; 142(5):708-9. PubMed ID: 3892917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-class medicine returns to the United States: impact of Medi-Cal reform.
    Waitzkin H
    Lancet; 1984 Nov; 2(8412):1144-6. PubMed ID: 6150193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
    Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
    Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender Differences in Physician Service Provision Using Medicare Claims Data.
    Mahr MA; Hayes SN; Shanafelt TD; Sloan JA; Erie JC
    Mayo Clin Proc; 2017 Jun; 92(6):870-880. PubMed ID: 28501293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physician Specialty and Radiologist Characteristics Associated with Higher Medicare Patient Complexity.
    Rosenkrantz AB; Wang W; Vijayasarathi A; Duszak R
    Acad Radiol; 2018 Feb; 25(2):219-225. PubMed ID: 29103917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Children in foster care in California: an examination of Medicaid reimbursed health services utilization.
    Halfon N; Berkowitz G; Klee L
    Pediatrics; 1992 Jun; 89(6 Pt 2):1230-7. PubMed ID: 1594381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Physician Data in Two Data Files Available for Cancer Health Services Research.
    White DP; Enewold L; Geiger AM; Banks R; Warren JL
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):66-71. PubMed ID: 32412069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.